The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Optiray 300 mg I/ml solution for injection or infusion


Main Information

Trade NameOptiray 300 mg I/ml solution for injection or infusion
Active SubstancesIoversol
Dosage FormSolution for injection/infusion
Licence HolderGuerbet
Licence NumberPA0686/007/003

Group Information

ATC CodeV08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
V08AB07 ioversol


License statusAuthorised
Licence Issued22/04/1993
Legal statusProduct subject to Restricted Prescription (C)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back